近70%患有类阿片使用紊乱症的医疗救助病人在六个月内没有获得经过证实的药物治疗, Nearly 70% of Medicaid patients with opioid use disorder didn’t get proven medication treatment within six months, with racial disparities and proposed funding cuts raising concerns.

对被诊断患有类阿片使用紊乱症的100多万名医疗补助病人进行的一项新研究发现,近70%的病人在六个月内没有接受药物治疗,尽管已证实丁丙诺啡和美沙酮等药物是有效的。 A new study of over a million Medicaid patients diagnosed with opioid use disorder finds nearly 70% didn’t receive medication treatment within six months, despite proven effectiveness of drugs like buprenorphine and methadone. 黑西班牙裔和西班牙裔病人获得治疗的可能性较小,特别是美沙酮,因为美沙酮将过量吸毒风险降低86%。 Black and Hispanic patients were less likely to access care, especially methadone, which cuts overdose risk by 86%. 四年来,治疗率略有上升,从27%升至34%,但大多数仍未得到治疗。 Treatment rates rose slightly from 27% to 34% over four years, but most remain untreated. 研究人员敦促改变政策以扩大准入范围,警告说,拟议削减医疗援助计划的资金可能会使危机恶化。 Researchers urge policy changes to expand access, warning that proposed Medicaid funding cuts could worsen the crisis.